This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Health Care Funds That Can Continue Rallying

NEW YORK (TheStreet) -- Health stocks have been rallying. During the past year, the average health mutual fund returned 23.9%, while the S&P 500 gained 12.3%, according to Morningstar. Biotech stocks have been especially strong performers. With many companies winning drug approvals, Fidelity Select Biotechnology (FBIOX) returned 43.1% in the past year.

Can the health stocks remain market favorites? Probably. The outlook for sales and earnings is strong. If President Obama wins reelection, his signature health reform legislation will proceed, offering insurance coverage to 30 million people. That will provide new customers for hospitals and pharmaceutical companies.

If Gov. Romney wins, the implementation of Obamacare could slow. But chances are that the Republicans will not be able to stop the program altogether. Recent polls suggest that Democrats will maintain control of the Senate, giving them leverage to block efforts at repeal.

If you want to wager that the demand for pharmaceuticals and medical devices will remain strong, consider buying a health care mutual fund. But keep in mind that health care funds follow different strategies.





Some funds emphasize fast-growing biotech and drug companies, while other choices take a tamer approach, focusing on stable companies with slower growth and modest valuations. Funds in the growth camp include Alger Health Sciences (AHSAX), Eaton Vance Worldwide Health Sciences (ETHSX), and T. Rowe Price Health Sciences (PRHSX).

Funds that focus on pharmaceutical giants and other stable choices include Live Oak Health Sciences (LOGSX), Schwab Health Care (SWHFX) and Vanguard Health Care (VGHCX).

A solid choice in the growth camp is Eaton Vance Worldwide Health Sciences. During the past five years, the fund returned 6.1% annually, outpacing 68% of peers. Investors seeking a more mild-mannered fund should consider Live Oak Health Sciences, which returned 6.3% annually.

While Eaton Vance and Live Oak have had similar returns, the managers of the two funds hold very different views. Sam Isaly, Eaton Vance's portfolio manager, argues that the future is bright for biotechnology companies.





Mark Oelschlager of Live Oak says that many of the strong performers are too expensive for his tastes. Instead, he is focusing on unloved device makers and pharmaceutical distributors.

Seeking to find the best growth in the health sector, Isaly has 20% of his assets in biotechnology. He says that the biotechnology companies are proving to be powerful innovators, accounting for half of all new drug approvals in the U.S.

Stock quotes in this article: AHSAX, ETHSX, PRHSX, LOGSX, SWHFX, VGHCX, GILD, RHHBY, SYK, MCK 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs